Allergan Sues Lupin Over Zymaxid Patents
Allergan Inc. and two Japanese pharmaceutical companies sued Lupin Ltd. in Delaware on Thursday, claiming the company's proposed generic version of pinkeye treatment Zymaxid infringes their patents....To view the full article, register now.
Already a subscriber? Click here to view full article